ENTX Annual SG&A
$4.43 M
-$2.82 M-38.92%
31 December 2023
Summary:
As of January 22, 2025, ENTX annual selling, general & administrative expenses is $4.43 million, with the most recent change of -$2.82 million (-38.92%) on December 31, 2023. During the last 3 years, it has fallen by -$421.00 thousand (-8.68%). ENTX annual SG&A is now -48.34% below its all-time high of $8.57 million, reached on December 31, 2017.ENTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENTX Quarterly SG&A
$1.54 M
+$456.00 K+41.91%
30 September 2024
Summary:
As of January 22, 2025, ENTX quarterly selling, general & administrative expenses is $1.54 million, with the most recent change of +$456.00 thousand (+41.91%) on September 30, 2024. Over the past year, it has increased by +$217.00 thousand (+16.35%). ENTX quarterly SG&A is now -53.33% below its all-time high of $3.31 million, reached on December 31, 2017.ENTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENTX TTM SG&A
-$430.91 M
-$9.18 M-2.18%
30 September 2024
Summary:
As of January 22, 2025, ENTX TTM selling, general & administrative expenses is -$430.91 million, with the most recent change of -$9.18 million (-2.18%) on September 30, 2024. Over the past year, it has dropped by -$435.37 million (-9755.08%). ENTX TTM SG&A is now -1307.45% below its all-time high of $9.34 million, reached on March 31, 2018.ENTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.9% | +16.4% | -9755.1% |
| 3 y3 years | -8.7% | +36.0% | -7753.8% |
| 5 y5 years | +55.8% | +36.0% | -7753.8% |
ENTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.9% | at low | -28.9% | +58.7% | -25.9% | at low |
| 5 y | 5-year | -38.9% | +3.5% | -28.9% | +86.3% | -110.1% | at low |
| alltime | all time | -48.3% | +179.3% | -53.3% | +477.5% | -1307.5% | at low |
Entera Bio Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.54 M(+41.9%) | $4.93 M(+11.7%) |
| June 2024 | - | $1.09 M(-18.0%) | $4.42 M(-1.1%) |
| Mar 2024 | - | $1.33 M(+36.4%) | $4.46 M(+0.7%) |
| Dec 2023 | $4.43 M(-38.9%) | $973.00 K(-5.4%) | $4.43 M(-14.8%) |
| Sept 2023 | - | $1.03 M(-9.4%) | $5.20 M(-7.7%) |
| June 2023 | - | $1.14 M(-12.3%) | $5.63 M(-11.7%) |
| Mar 2023 | - | $1.29 M(-25.7%) | $6.38 M(-12.1%) |
| Dec 2022 | $7.25 M(+27.5%) | $1.74 M(+19.2%) | $7.25 M(+3.7%) |
| Sept 2022 | - | $1.46 M(-22.3%) | $6.99 M(-1.1%) |
| June 2022 | - | $1.88 M(-13.4%) | $7.07 M(+7.9%) |
| Mar 2022 | - | $2.17 M(+46.5%) | $6.55 M(+15.1%) |
| Dec 2021 | $5.69 M(+17.3%) | $1.48 M(-3.5%) | $5.69 M(+5.3%) |
| Sept 2021 | - | $1.53 M(+12.5%) | $5.40 M(+15.0%) |
| June 2021 | - | $1.36 M(+4.2%) | $4.70 M(-3.6%) |
| Mar 2021 | - | $1.31 M(+9.5%) | $4.87 M(+0.4%) |
| Dec 2020 | $4.85 M | $1.20 M(+44.1%) | $4.85 M(-6.4%) |
| Sept 2020 | - | $829.00 K(-46.1%) | $5.18 M(-4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $1.54 M(+19.1%) | $5.42 M(+20.1%) |
| Mar 2020 | - | $1.29 M(-15.4%) | $4.51 M(+5.5%) |
| Dec 2019 | $4.28 M(+50.6%) | $1.52 M(+42.0%) | $4.28 M(+16.1%) |
| Sept 2019 | - | $1.07 M(+70.9%) | $3.69 M(+0.4%) |
| June 2019 | - | $628.00 K(-40.5%) | $3.67 M(+39.3%) |
| Mar 2019 | - | $1.06 M(+13.7%) | $2.64 M(-7.3%) |
| Dec 2018 | $2.84 M(-66.8%) | $929.00 K(-12.4%) | $2.84 M(-45.6%) |
| Sept 2018 | - | $1.06 M(-359.2%) | $5.22 M(-20.1%) |
| June 2018 | - | -$409.00 K(-132.4%) | $6.54 M(-30.0%) |
| Mar 2018 | - | $1.26 M(-61.8%) | $9.34 M(+15.6%) |
| Dec 2017 | $8.57 M(+215.4%) | $3.31 M(+39.4%) | $8.07 M(+55.6%) |
| Sept 2017 | - | $2.37 M(-0.8%) | $5.19 M(+56.2%) |
| June 2017 | - | $2.39 M(+465.5%) | $3.32 M(+54.0%) |
| Dec 2016 | $2.72 M(+71.4%) | $423.00 K(-16.6%) | $2.16 M(+24.4%) |
| Sept 2016 | - | $507.00 K(-58.7%) | $1.73 M(+41.3%) |
| June 2016 | - | $1.23 M | $1.23 M |
| Dec 2015 | $1.59 M | - | - |
FAQ
- What is Entera Bio annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Entera Bio?
- What is Entera Bio annual SG&A year-on-year change?
- What is Entera Bio quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Entera Bio?
- What is Entera Bio quarterly SG&A year-on-year change?
- What is Entera Bio TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Entera Bio?
- What is Entera Bio TTM SG&A year-on-year change?
What is Entera Bio annual selling, general & administrative expenses?
The current annual SG&A of ENTX is $4.43 M
What is the all time high annual SG&A for Entera Bio?
Entera Bio all-time high annual selling, general & administrative expenses is $8.57 M
What is Entera Bio annual SG&A year-on-year change?
Over the past year, ENTX annual selling, general & administrative expenses has changed by -$2.82 M (-38.92%)
What is Entera Bio quarterly selling, general & administrative expenses?
The current quarterly SG&A of ENTX is $1.54 M
What is the all time high quarterly SG&A for Entera Bio?
Entera Bio all-time high quarterly selling, general & administrative expenses is $3.31 M
What is Entera Bio quarterly SG&A year-on-year change?
Over the past year, ENTX quarterly selling, general & administrative expenses has changed by +$217.00 K (+16.35%)
What is Entera Bio TTM selling, general & administrative expenses?
The current TTM SG&A of ENTX is -$430.91 M
What is the all time high TTM SG&A for Entera Bio?
Entera Bio all-time high TTM selling, general & administrative expenses is $9.34 M
What is Entera Bio TTM SG&A year-on-year change?
Over the past year, ENTX TTM selling, general & administrative expenses has changed by -$435.37 M (-9755.08%)